Wednesday, October 21, 2020
wellness India Expo
Home Tags Cipla

Tag: Cipla

Stempeucel, first ‘Made in India’ cell therapy to treat Critical Limb...

Developed by Stempeutics over a period of twelve years, the breakthrough treatment designed to address the root cause of Critical Limb Ischemia at an affordable cost will be marketed and distributed in India by Cipla.....................

Cipla gets regulatory nod to launch Ciplenza for mild & moderate...

Cipla Limited has announced that it has been granted regulatory approval by the Drug Controller General of India (DCGI) for the launch of Favipiravir in the country under the brand name Ciplenza.................

Cipla expands partnership with Roche Pharma to improve access to key...

Cipla signs a distribution agreement with Roche Products (India) Pvt. Ltd. to expand scope of the partnership to include, marketing and distribution of Roche’s trademark oncology drugs - Trastuzumab (Herclon), Bevacizumab (Avastin) and Rituximab (Ristova) in India.........................

“We aim to bring newer drug innovations to the Indian market”

Mentioned Luca Visini, Managing Director, Eli Lilly & Company India in an exclusive interaction with BioVoice where he outlined the goals of his company driven by innovation including pursual of new drug development and working towards medicines reaching people at large through different channels.....................

CDRI Lucknow celebrates its 69th annual day, hosts talk by Cipla...

"We are at the threshold of an Indian scientific revolution. This requires us to rethink, redesign and rebuilt our scientific base through appropriate technology” said Dr Y K Hamied while delivering the 45th Sir Mellanby oration.......................

Cipla Foundation sets up a state-of-the-art chemistry laboratory at IISER Pune

The lab aims to provide practical training in Chemistry to undergraduates and researchers in the varsity campus along with support to the national outreach programme for school children..................

CSIR-CDRI and Cipla signed an agreement for collaboration to develop new...

CSIR-CDRI and Cipla's public-private-partnership for research and development is expected to pave the way for new innovative drugs................

Cipla acquires novel anti-infective Elores to further anti-microbial stewardship in critical...

Product to strengthen Cipla’s historic leadership in the anti-infectives space in India, and reinforce play in the Indian branded market. Acquisition in keeping with Cipla’s legacy of access to life-saving drugs and work in anti-microbial stewardship..............

Alvotech & Cipla Gulf join hands to commercialize key biosimilar in...

Under the partnership, Alvotech will be responsible for development and supply of AVT02, an adalimumab biosimilar, in select emerging markets., while Cipla Gulf will be responsible for registration and commercialization....................

Cipla USA furthers AMR stewardship with acquisition of key anti-infective ZEMDRI

Cipla USA to hold worldwide rights (excluding Greater China) of ZEMDRI™ (IV Plazomicin), an IV aminoglycoside with once-daily dosing for cUTI in adults, with proven activity against certain drug-resistant bacteria.......................